Dr Reddy

Dr. Reddy’s Laboratories Ltd. announced the launch of Cresp- the first generic darbepoetin alfa in the world, and the only darbepoetin alfa in India. Cresp has been approved in India for the treatment of anemia due to chronic kidney disease and anemia due to chemotherapy.Darbepoetin alfa is a modified version of epoetin alfa (rHuEPO), which is engineered to have a longer half life, increasing (up to 3 times) the time it remains in the blood. This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anemia with epoetin which is the current standard of care in India.Dr. Reddy’s will be launching Cresp in both vials and prefilled syringes (PFS).

Follow and connect with us on Facebook, Twitter, LinkedIn, Elets video

Eletsonline News

Most Popular

Subscribe Newsletter
To Top